These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Singhasivanon P Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 4():i-iv, 1-101. PubMed ID: 10935286 [TBL] [Abstract][Full Text] [Related]
5. New recommendation for malaria treatment in Indonesia. Nelwan EJ Acta Med Indones; 2012 Jul; 44(3):185-6. PubMed ID: 23033407 [No Abstract] [Full Text] [Related]
6. A standard regimen for treatment of plasmodium vivax malaria. Patwari AK Indian Pediatr; 1996 Sep; 33(9):792-4. PubMed ID: 9057417 [No Abstract] [Full Text] [Related]
7. Real-world therapies and the problem of vivax malaria. Baird JK N Engl J Med; 2008 Dec; 359(24):2601-3. PubMed ID: 19064622 [No Abstract] [Full Text] [Related]
8. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. Maguire JD; Krisin ; Marwoto H; Richie TL; Fryauff DJ; Baird JK Clin Infect Dis; 2006 Apr; 42(8):1067-72. PubMed ID: 16575721 [TBL] [Abstract][Full Text] [Related]
11. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan. Kolaczinski K; Durrani N; Rahim S; Rowland M Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447 [TBL] [Abstract][Full Text] [Related]
12. [One case of malaria with repeated attacks]. Yang HL; Zhang ZY Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):200. PubMed ID: 12568017 [No Abstract] [Full Text] [Related]
13. Emerging chloroquine-resistant Plasmodium vivax (Benign Tertian) malaria: the need for alternative drug treatment. Vinetz JM Clin Infect Dis; 2006 Apr; 42(8):1073-4. PubMed ID: 16575722 [No Abstract] [Full Text] [Related]
14. Malaria trends and challenges in the Greater Mekong Subregion. Delacollette C; D'Souza C; Christophel E; Thimasarn K; Abdur R; Bell D; Dai TC; Gopinath D; Lu S; Mendoza R; Ortega L; Rastogi R; Tantinimitkul C; Ehrenberg J Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):674-91. PubMed ID: 19842400 [TBL] [Abstract][Full Text] [Related]
15. Antimalarial chemotherapy: the old and the new perspectives. Mukherjee N J Assoc Physicians India; 1998 Nov; 46(11):959-63. PubMed ID: 11229225 [No Abstract] [Full Text] [Related]
16. Modifying national malaria treatment policies in Peru. Ruebush TK; Neyra D; Cabezas C J Public Health Policy; 2004; 25(3-4):328-45. PubMed ID: 15683069 [TBL] [Abstract][Full Text] [Related]
17. Artemisinin derivatives and malaria: useful, in combination with other antimalarials. Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494 [TBL] [Abstract][Full Text] [Related]
18. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea. Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359 [TBL] [Abstract][Full Text] [Related]
19. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Snounou G; White NJ Trends Parasitol; 2004 Jul; 20(7):333-9. PubMed ID: 15193565 [No Abstract] [Full Text] [Related]
20. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]